TheraDiag SA (ALTER) - Medical Equipment - Deals and Alliances Profile.
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA is a biotechnology company that develops, manufactures, and markets in-vitro diagnostic products. The company provides product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company offers services in the autoimmune disease diagnostic market. Theradiag is headquartered in Marne-la-Vallee, France.
TheraDiag SA (ALTER) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA is a biotechnology company that develops, manufactures, and markets in-vitro diagnostic products. The company provides product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company offers services in the autoimmune disease diagnostic market. Theradiag is headquartered in Marne-la-Vallee, France.
TheraDiag SA (ALTER) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 4
List of Figures 5
TheraDiag SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
TheraDiag SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
TheraDiag SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
TheraDiag SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
TheraDiag SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
TheraDiag SA, Medical Equipment, Deal Details 11
Partnerships 11
Miraca Life Sciences Enters into Licensing Agreement with Theradiag 11
HOB Biotech Enters into Distribution Agreement with Theradiag 11
Theradiag Enters into Distribution Agreement with HOB Biotech 12
TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 13
Theradiag Enters Into Co-Development Agreement With CNRS, IGMM And University of Montpellier 13
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 14
TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 15
TheraDiag Enters Into Agreement With Splicos And French National Center for Research 16
Theradiag Enters Into Co-Development Agreement With Sebia For New Diagnostic Kit 17
Equity Offering 18
TheraDiag to Raise up to USD4.4 Million in Private Placement of Shares 18
TheraDiag Raises USD2.78 Million in Private Placement of Shares 19
TheraDiag Raises Funds in IPO of Shares 19
TheraDiag SA - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 24
Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 25
Mar 01, 2017: THERADIAG: Full-year 2016 results 26
Oct 13, 2016: THERADIAG: Very strong revenue growth at end-September 2016: +31% 29
Sep 14, 2016: THERADIAG: First-half 2016 Revenues and Results 30
Jul 05, 2016: Theradiag: Very strong revenue growth in the first half of 2016: +36% 31
Apr 25, 2016: Theradiag: First-quarter 2016 revenues up 50% 32
Mar 10, 2016: Theradiag: Full-year 2015 results 33
Feb 08, 2016: THERADIAG 2015 revenues: very strong sales growth of Lisa Tracker kits 35
Corporate Communications 36
Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiags Board of Directors 36
Jul 11, 2016: THERADIAG Appoints Vincent Fert to Theradiags Board of Directors 37
Jul 11, 2016: Vincent Fert appointed to Theradiags Board of Directors 38
Product News 39
Jun 16, 2016: LISA TRACKER launched in the US market 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List Of Tables
TheraDiag SA, Medical Equipment, Key Facts 1
TheraDiag SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
TheraDiag SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
TheraDiag SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
TheraDiag SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
TheraDiag SA, Deals By Market, 2011 to YTD 2017 9
TheraDiag SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Miraca Life Sciences Enters into Licensing Agreement with Theradiag 11
HOB Biotech Enters into Distribution Agreement with Theradiag 11
Theradiag Enters into Distribution Agreement with HOB Biotech 12
TheraDiag Enters into Co-Development Agreement with Unicancer and Bordeaux University 13
Theradiag Enters Into Co-Development Agreement With CNRS, IGMM And University of Montpellier 13
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 14
TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 15
TheraDiag Enters Into Agreement With Splicos And French National Center for Research 16
Theradiag Enters Into Co-Development Agreement With Sebia For New Diagnostic Kit 17
TheraDiag to Raise up to USD4.4 Million in Private Placement of Shares 18
TheraDiag Raises USD2.78 Million in Private Placement of Shares 19
TheraDiag Raises Funds in IPO of Shares 19
TheraDiag SA, Key Competitors 21
TheraDiag SA, Key Employees 22
TheraDiag SA, Subsidiaries 23
List Of Figures
TheraDiag SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
TheraDiag SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
TheraDiag SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
TheraDiag SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
TheraDiag SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
TheraDiag SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
TheraDiag SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
TheraDiag SA, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
RELATED REPORTS
TheraDiag SA (ALTER) - Financial and Strategic SWOT Analysis Review
TheraDiag SA (ALTER) - Financial and Strategic SWOT Analysis Review
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
